Metabolic control and diabetic retinopathy

Current Diabetes Reviews

Volumn 5, Issue 1, 2009, Pages 3-7

  Rodriguez Fontal, Monica ^a   Kerrison, John B ^a   Alfaro, D Virgil ^a   Jablon, Eric P ^a  

^a Charleston Neuroscience Institute   (United States)

Author keywords

Diabetes; Diabetic retinopathy; Hyperglycemia; Metabolic control

Indexed keywords

HEMOGLOBIN A1C; INSULIN; SULFONYLUREA DERIVATIVE;

CLINICAL TRIAL; DIABETES CONTROL; DIABETIC RETINOPATHY; GLYCEMIC CONTROL; HEMATOCRIT; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LASER COAGULATION; LIPID BLOOD LEVEL; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; VISUAL IMPAIRMENT; BLOOD; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; METABOLISM; PATHOPHYSIOLOGY; REFERENCE VALUE; RETINA MACULA EDEMA;

BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; HYPERGLYCEMIA; MACULAR EDEMA; REFERENCE VALUES;

EID: 65549146650     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909787314176     Document Type: Review

References (20)

1. Brinchmann-Hansen O, Dahl-Jorgensen K, Hannsen K, et al. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Arch Ophthalmol 1988; 106: 1242-6.
2. Lauritzen T, Frost-Larsen K, Larsen H, et al. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34(Suppl.): 74-9.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
4. Reichard P, Nilsson B, Rosenqvist U. Retardation of the development of microvascular complications after long-term intensified insulin treatment: the Stockholm Diabetes Intervention Study. N Engl J Med 1993; 329: 304-9.
5. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 1995; 113: 36-51.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
7. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-Term results of the Kumamoto Study on optiomal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23(suppl.): 21-9.
8. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-9.
9. Davis MD. Diabetic retinopathy: a clinical overview [see comments]. Diabetes Care 1992; 15: 1844-74.
10. Chantelau E, Kohner E. Why some cases of retinopathy worsen when diabetic control improves: worsening retinopathy is not a reason to withhold intensive insulin treatment. Br Med J 1997; 315: 1105-6.
11. Agardh CD, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabetes Complications 1992; 6: 96-100.
12. Moskalets E, Galstyan G, Starostina E, et al. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabetes Complcations 1994; 8: 45-50.
13. Henricsson M, Nilsson A, Janzon L, et al. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in noninsulin-dependent diabetes mellitus. Diabetes Med 1997; 14: 123-31.
14. Roysarkar TK, Gupta A, Dash RJ, et al. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus. Am J Ophthalmol 1993; 115: 569-74.
15. Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1998; 116: 874-86.
16. Davis M, Fisher M, Gangnon R, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment of Diabetic Retinopathy Study report no. 18. Invest Ophthalmol Vis Sci 1998; 39: 233-52.
17. Klein R, Klein B, Moss S. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992; 15: 1875-91.
18. Chew EY, Klein ML, Ferris FL III, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report no. 22. Arch Ophthalmol 1996; 114: 1079-84.
19. Qiao Q, Keinanen-Kiukaanniemi S, Laara E. The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 1997; 50: 153-8.
20. Shorb SR. Anemia and diabetic retinopathy. Am J Ophthalmol 1985; 100: 434-6.